epoetin alfa-epbx 10000 UNT/ML Injectable Solution [Retacrit]
RxNorm concept 2463733, branded drug (sbd). Prescribable name: Retacrit 10,000 UNT/ML Injectable Solution.
- RxCUI
- 2463733
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2463733 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
EPO-epbx 10000 UNT/ML Injectable Solution [Retacrit]; ERYTHROPOIETIN-epbx 10000 UNT/ML Injectable Solution [Retacrit]; Retacrit (epoetin alfa-epbx 20,000 UNT per 2 ML) Injectable Solution; Retacrit 10000 UNT/ML Injectable Solution
Related concepts
- epoetin alfa-epbx 10000 UNT/ML (SCDC, consists of)
- epoetin alfa-epbx 10000 UNT/ML [Retacrit] (SBDC, consists of)
- Injectable Solution (DF, has dose form)
- Retacrit (BN, has ingredient)
- epoetin alfa-epbx 10000 UNT/ML Injectable Solution (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2463733 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2463733 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2463733. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.